On Thursday the market punished the obvious names. PB Fintech fell as much as 36%, wiping roughly ₹31,426 crore of market value (The Economic Times), and Moneycontrol counted ₹4.1 lakh crore of market cap gone across 12 financial stocks. The trigger was IRDAI's consultation paper on the economics of insurance distribution, open for feedback until 25 October 2026.

Read the actual proposals, though, and the sharpest blade is aimed not at insurers or aggregators but at lenders. The draft would cap commission on credit life at 2%, against roughly 28% today; take loan-packaged motor third-party cover to nil; cut motor own-damage to 5% from about 16%; and squeeze health distributor payouts into a 15–20% band.

Separately, IRDAI wants to ban making insurance a condition of loan approval, and to require lenders to quote loans both with and without cover. That second piece matters more than the rate caps: caps shrink the fee, but the bundling ban attacks the attach rate itself.

Filings show which listed lenders turned loan-attached insurance into a profit engine.

Capri Global: 12% of pre-tax profit, and accelerating

Capri Global Capital (CGCL) is the clearest case in the corpus. Its Q4 FY26 investor presentation breaks out insurance distribution as its own P&L line: ₹1,519 million (₹152 crore) in FY26, up from ₹628 million in FY25 — 2.4x in a single year. Against FY26 profit before tax of ₹12,569 million, that one line is roughly 12% of pre-tax profit. Because distribution commission carries no funding cost and little incremental operating expense, nearly all of it drops through to the bottom line.

Its own RoAA tree shows the slope: insurance distribution contributed 0.5% of average assets in every quarter from Q4 FY25 through Q3 FY26, then jumped to 0.9% in Q4 FY26.

Crucially, the filings are explicit that this is loan-attached business. CGCL's H1 FY26 presentation describes "Insurance Product offering to Loan customers as embedded product," lists "Credit Life Cover" and "EMI Protect" among its products, and splits H1 FY26 premium of ₹1,003 million by lending vertical: Housing 38.9%, Gold 30.0%, MSME 29.6%. By product type, Life is 54.0% of premium. Life cover sold to gold-loan and MSME borrowers is, in practice, credit life — the exact line IRDAI wants taken to 2%.

CreditAccess Grameen: management already named this risk out loud

CreditAccess Grameen's insurance distribution income went from ₹18.3 crore in FY23 to ₹91.9 crore in FY24 — a five-fold jump in one year, per its Q4 FY24 investor presentation.

Why it jumped is on the record. Then-MD Udaya Kumar Hebbar explained it on the October 2023 earnings call, and his words describe precisely the cycle now at risk of reversing: "We have been the corporate agent for many years. By regulation we used to get only a 5% commission till Q1 and now that IRDA has revised the pricing which allowed the insurers to give a higher commission which actually increased between 12% to 15% now."

He then added his own caveat — that this would be steady-state income "until and unless the regulator changes any fee cap or something."

The regulator is now proposing exactly that. A 2% cap on credit life would leave CreditAccess earning less than the 5% it made before the 2023 liberalisation.

Fusion Finance built the channel at the worst possible moment

Fusion Finance received its IRDAI Corporate Agency Licence in October 2025. Per its FY26 annual report, it then "onboarded four life insurance partners to offer Group Credit Life insurance for its Microfinance portfolio."

Its FY24 presentation states the attach rate on its business-loan book without euphemism: "Credit life insurance – 100%." A 100% attach rate is the definition of what IRDAI's bundling ban is written to stop. Fusion spent a year standing up a channel whose economics are now under consultation.

Where the exposure is thinner than the selloff implied

Bajaj Finance, named in Thursday's selloff, discloses in its FY25 annual report a related-party approval for commission receivable from Bajaj Allianz Life "not exceeding ₹670 crore for FY2026," governed by IRDAI's Expenses of Management (including Commission of Insurers) Regulations, 2024 — the very framework now being tightened. But that is a ceiling on commission from one related insurer, and the filing does not size it against group profit. Karnataka Bank reports "Commission on Insurance & Mutual Fund" of ₹137 crore in FY26, up from ₹78 crore in FY24, against FY26 PAT of ₹1,311 crore. Two caveats cut that exposure: the line bundles insurance with mutual funds, and Q1 FY27 has already softened to ₹24 crore from ₹37 crore in Q4 FY26. SBI Cards is the cleanest proof this is not a sector-wide problem: its board filings show "Insurance commission income" of just ₹3.22 crore for a full year against ₹18,072 crore of revenue from operations — a rounding error.

On the insurer side the dependence is real too: Max Financial's FY24 transcript notes "our Group Credit Life business grew by 62%, contributing to an overall company level APE growth of 19%," alongside 20 new Group Credit Life partners onboarded that year.

What retail investors should do

Do not trade the headline. This is a consultation paper, not a regulation — feedback closes 25 October 2026, and the history of the 2023 EoM reforms shows IRDAI does soften drafts under industry pressure. Insurers and aggregators have already been repriced hard; the less-examined risk sits in the fee lines of lenders.

Something concrete: open the last annual report of any lender you own and find the "fee and commission income" or "other income" note. If insurance distribution is broken out and has grown several-fold since FY24 — as at Capri Global and CreditAccess Grameen — you own a profit stream built on commission rates a regulator has now put in writing that it wants cut by 80–90%. If it isn't broken out at all, as at SBI Cards, this story isn't yours.

Size that line against pre-tax profit, not revenue. Fee income carrying no funding cost is disproportionately profit — which is why a line worth 5% of revenue can be worth 12% of earnings.

Data sourced from company filings on NSE via Xaro.